| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ZnF_C2HC | 5.00e-08 | 55 | 117 | 7 | SM00343 | |
| Domain | Znf_CCHC | 5.00e-08 | 55 | 117 | 7 | IPR001878 | |
| Domain | DUF4599 | 5.06e-05 | 12 | 117 | 3 | PF15371 | |
| Domain | DUF4599 | 5.06e-05 | 12 | 117 | 3 | IPR027970 | |
| Domain | FAM47 | 2.32e-04 | 4 | 117 | 2 | PF14642 | |
| Domain | FAM47 | 2.32e-04 | 4 | 117 | 2 | IPR032743 | |
| Pubmed | FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.82e-23 | 25 | 128 | 12 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 3.50e-19 | 23 | 128 | 10 | 18602769 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | AOC1 FAM90A14 FAM90A1 FAM90A17 FAM90A19 FAM90A22 FAM90A26 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 1.19e-12 | 164 | 128 | 12 | 22967998 |
| Pubmed | MYC BRIX1 ZNF609 UBAP2 DEAF1 DHX37 BAG5 GON4L SRCAP CIT SIRT1 YEATS2 KMT2C NCOR2 RIF1 SALL1 PAX8 SEC16A OTUD4 YY1AP1 LTV1 | 6.16e-08 | 1429 | 128 | 21 | 35140242 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZNF609 GON4L FAM90A1 YEATS2 KMT2C NCOR2 SALL1 SEC16A YY1AP1 RPL3 | 2.35e-06 | 398 | 128 | 10 | 35016035 |
| Pubmed | SPEG GON4L CSMD3 YEATS2 ITSN2 SEC16A NAV1 OTUD4 YY1AP1 LRRC7 | 2.87e-06 | 407 | 128 | 10 | 12693553 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYC BRIX1 ZNF609 DEAF1 TRA2B CHAF1A SRCAP HNRNPC YEATS2 KMT2C NCOR2 ZNF106 RIF1 ZBTB39 KIF18B RPL3 SLC27A4 | 5.66e-06 | 1294 | 128 | 17 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DEAF1 CHAF1A HDAC7 HNRNPC SIRT1 YEATS2 NCOR2 ZNF106 RIF1 SEC16A OTUD4 YY1AP1 PRG4 | 6.01e-06 | 774 | 128 | 13 | 15302935 |
| Pubmed | 7.24e-06 | 125 | 128 | 6 | 29467281 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22245592 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 28938444 | ||
| Pubmed | Newly identified Gon4l/Udu-interacting proteins implicate novel functions. | 1.34e-05 | 2 | 128 | 2 | 32848183 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 18826608 | ||
| Pubmed | The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. | 1.34e-05 | 2 | 128 | 2 | 33864850 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25772107 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12509468 | ||
| Pubmed | Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation. | 1.34e-05 | 2 | 128 | 2 | 34864816 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23555306 | ||
| Pubmed | SIRT1 Limits Adipocyte Hyperplasia through c-Myc Inhibition. | 1.34e-05 | 2 | 128 | 2 | 26655722 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23024800 | ||
| Pubmed | The Justy mutation identifies Gon4-like as a gene that is essential for B lymphopoiesis. | 1.34e-05 | 2 | 128 | 2 | 20530203 | |
| Pubmed | A c-Myc-SIRT1 feedback loop regulates cell growth and transformation. | 1.34e-05 | 2 | 128 | 2 | 19364925 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23045412 | ||
| Pubmed | Histone Deacetylase SIRT1 Targets Plk2 to Regulate Centriole Duplication. | 1.34e-05 | 2 | 128 | 2 | 30517871 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYC BRIX1 TRA2B DHX37 CHAF1A HDAC7 HNRNPC KMT2C SUSD2 GYS1 OTUD4 LRRC7 POLQ RPL3 SLC27A4 STK25 | 2.08e-05 | 1284 | 128 | 16 | 17353931 |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 2.25e-05 | 91 | 128 | 5 | 34780483 | |
| Pubmed | 2.63e-05 | 233 | 128 | 7 | 37704626 | ||
| Pubmed | 2.70e-05 | 234 | 128 | 7 | 36243803 | ||
| Pubmed | BRIX1 TRA2B CHAF1A GON4L SRCAP CEP43 CCDC66 SEC16A NAV1 PPP1R9B KIF18B | 2.81e-05 | 645 | 128 | 11 | 25281560 | |
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 3.54e-05 | 50 | 128 | 4 | 29560723 | |
| Pubmed | 3.58e-05 | 335 | 128 | 8 | 15741177 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28381640 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 32684624 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33186656 | ||
| Pubmed | MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. | 4.02e-05 | 3 | 128 | 2 | 26046375 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22072270 | ||
| Pubmed | SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. | 4.02e-05 | 3 | 128 | 2 | 22986535 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23797802 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22448750 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25280219 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 15198123 | ||
| Pubmed | Sirt1 deacetylates c-Myc and promotes c-Myc/Max association. | 4.02e-05 | 3 | 128 | 2 | 21807113 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 25487600 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 29518496 | ||
| Pubmed | SIRT1 Activation Attenuates Bone Cancer Pain by Inhibiting mGluR1/5. | 4.02e-05 | 3 | 128 | 2 | 31270711 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 35343073 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23608756 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 30720110 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28467182 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 23970286 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22190494 | ||
| Pubmed | 5.27e-05 | 260 | 128 | 7 | 36199071 | ||
| Pubmed | KCTD9 UBAP2 TRA2B GRM1 CIT SHANK3 NCOR2 KCNB1 SEC16A NAV1 OTUD4 PPP1R9B LRRC7 | 5.85e-05 | 963 | 128 | 13 | 28671696 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPEG ANKLE1 SRCAP BIRC6 CIT HDAC7 PCNX2 LPIN3 KMT2C NCOR2 SEC16A NAV1 LRP5 PDZD8 | 5.93e-05 | 1105 | 128 | 14 | 35748872 |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 5.94e-05 | 57 | 128 | 4 | 23080069 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 6.05e-05 | 361 | 128 | 8 | 30344098 | |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 6.17e-05 | 21 | 128 | 3 | 27626377 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MYC BRIX1 TRA2B DHX37 CHAF1A HNRNPC NCOR2 ZNF106 RIF1 PDZD8 KIF18B RPL3 SLC27A4 | 7.64e-05 | 989 | 128 | 13 | 36424410 |
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 33462212 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 21139137 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 31930333 | ||
| Pubmed | 8.02e-05 | 4 | 128 | 2 | 36163081 | ||
| Pubmed | ZNF609 UBAP2 CHAF1A BIRC6 YEATS2 ZNF106 NEO1 SEC16A NAV1 PDZD8 SLC27A4 | 8.84e-05 | 733 | 128 | 11 | 34672954 | |
| Pubmed | 9.31e-05 | 24 | 128 | 3 | 33722704 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 PCDH11Y INSR ZDHHC14 ZSWIM1 CEP43 HNRNPC PCNX2 YEATS2 KMT2C NCOR2 EEPD1 NAV1 LRP5 PPP1R9B LRRC7 | 1.20e-04 | 1489 | 128 | 16 | 28611215 |
| Pubmed | MUC16 CCDC85A YEATS2 NCOR2 SALL1 GYS1 ITSN2 OTUD4 LTV1 HERC6 | 1.31e-04 | 638 | 128 | 10 | 31182584 | |
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 21454521 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 30777853 | ||
| Pubmed | 1.33e-04 | 5 | 128 | 2 | 10640276 | ||
| Pubmed | Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. | 1.33e-04 | 5 | 128 | 2 | 15175761 | |
| Pubmed | 2.00e-04 | 6 | 128 | 2 | 25279712 | ||
| Pubmed | 2.00e-04 | 6 | 128 | 2 | 23085571 | ||
| Pubmed | 2.00e-04 | 6 | 128 | 2 | 16956611 | ||
| Pubmed | Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1. | 2.00e-04 | 6 | 128 | 2 | 33504783 | |
| Pubmed | 2.68e-04 | 34 | 128 | 3 | 23300479 | ||
| Pubmed | CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation. | 2.79e-04 | 7 | 128 | 2 | 20332113 | |
| Pubmed | Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. | 2.79e-04 | 7 | 128 | 2 | 12970571 | |
| Pubmed | Orientation-specific joining of AID-initiated DNA breaks promotes antibody class switching. | 2.79e-04 | 7 | 128 | 2 | 26308889 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PLK2 UBAP2 TRA2B TRPM7 NTRK3 HDAC7 LPIN3 FSIP2 ZNF106 SEC16A NAV1 | 3.54e-04 | 861 | 128 | 11 | 36931259 |
| Pubmed | A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. | 3.71e-04 | 8 | 128 | 2 | 20852632 | |
| Pubmed | 3.71e-04 | 8 | 128 | 2 | 33504453 | ||
| Pubmed | Differential expression of HDAC and HAT genes in atrophying skeletal muscle. | 3.71e-04 | 8 | 128 | 2 | 26372908 | |
| Pubmed | 3.74e-04 | 38 | 128 | 3 | 28680062 | ||
| Pubmed | 4.55e-04 | 486 | 128 | 8 | 20936779 | ||
| Pubmed | A protein interaction network for pluripotency of embryonic stem cells. | 4.69e-04 | 41 | 128 | 3 | 17093407 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC TRA2B DHX37 SRCAP BIRC6 HNRNPC NCOR2 RIF1 TPP1 SEC16A LTV1 KIF18B RPL3 SLC27A4 | 4.75e-04 | 1353 | 128 | 14 | 29467282 |
| Pubmed | Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. | 4.76e-04 | 9 | 128 | 2 | 11466315 | |
| Pubmed | 4.76e-04 | 9 | 128 | 2 | 21423180 | ||
| Pubmed | The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities. | 4.76e-04 | 9 | 128 | 2 | 12237455 | |
| Pubmed | 4.76e-04 | 9 | 128 | 2 | 28130356 | ||
| Pubmed | 4.76e-04 | 9 | 128 | 2 | 19244234 | ||
| Pubmed | 4.99e-04 | 493 | 128 | 8 | 15368895 | ||
| Pubmed | 5.84e-04 | 103 | 128 | 4 | 10574462 | ||
| Pubmed | 5.84e-04 | 103 | 128 | 4 | 10819331 | ||
| Pubmed | In vivo role of different domains and of phosphorylation in the transcription factor Nkx2-1. | 5.93e-04 | 10 | 128 | 2 | 21345181 | |
| Pubmed | Multiple tumor suppressor pathways negatively regulate telomerase. | 5.93e-04 | 10 | 128 | 2 | 12837246 | |
| Pubmed | 5.93e-04 | 10 | 128 | 2 | 25261932 | ||
| Pubmed | 5.93e-04 | 10 | 128 | 2 | 20124353 | ||
| Pubmed | 6.06e-04 | 104 | 128 | 4 | 9205841 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.28e-04 | 281 | 128 | 6 | 28706196 | |
| Interaction | SMG7 interactions | SECISBP2L ZNF609 SIRT1 PRMT6 YEATS2 NCOR2 ZNF106 SALL1 SEC16A OTUD4 | 1.36e-05 | 319 | 114 | 10 | int:SMG7 |
| Interaction | MYO6 interactions | MYC TRA2B NTRK3 CIT HNRNPC TIPARP YEATS2 ITSN2 SEC16A PPP1R9B LTV1 | 1.62e-05 | 398 | 114 | 11 | int:MYO6 |
| Interaction | FAM90A26 interactions | 3.17e-05 | 2 | 114 | 2 | int:FAM90A26 | |
| Interaction | AKAP9 interactions | 3.74e-05 | 221 | 114 | 8 | int:AKAP9 | |
| Interaction | PABPC1 interactions | MYC BRIX1 UBAP2 TRA2B CHAF1A BAG5 CIT HNRNPC TDRD7 PRMT6 KMT2C OTUD4 PDZD8 RPL3 | 4.07e-05 | 699 | 114 | 14 | int:PABPC1 |
| Interaction | ANKRD28 interactions | 5.77e-05 | 235 | 114 | 8 | int:ANKRD28 | |
| Interaction | FBL interactions | MYC BRIX1 UBAP2 DHX37 CIT TIPARP PRMT6 SEC16A OTUD4 YY1AP1 LTV1 RPL3 MAP4K2 | 6.67e-05 | 639 | 114 | 13 | int:FBL |
| Interaction | PPP1CC interactions | SECISBP2L MYC BRIX1 DEAF1 TRA2B CIT HNRNPC SHANK3 RIF1 GYS1 ITSN2 NAV1 PPP1R9B RPL3 | 7.29e-05 | 738 | 114 | 14 | int:PPP1CC |
| Interaction | NR0B1 interactions | 7.58e-05 | 40 | 114 | 4 | int:NR0B1 | |
| Interaction | HBS1L interactions | 7.79e-05 | 125 | 114 | 6 | int:HBS1L | |
| Interaction | MOS interactions | 8.06e-05 | 78 | 114 | 5 | int:MOS | |
| Interaction | GOLGA1 interactions | 8.24e-05 | 183 | 114 | 7 | int:GOLGA1 | |
| Interaction | DCLK1 interactions | 8.51e-05 | 127 | 114 | 6 | int:DCLK1 | |
| Interaction | CPSF1 interactions | 1.02e-04 | 255 | 114 | 8 | int:CPSF1 | |
| Interaction | TFB1M interactions | 1.08e-04 | 83 | 114 | 5 | int:TFB1M | |
| Interaction | LGALS1 interactions | 1.14e-04 | 332 | 114 | 9 | int:LGALS1 | |
| Interaction | CDKN2A interactions | 1.22e-04 | 335 | 114 | 9 | int:CDKN2A | |
| Interaction | FXR1 interactions | MYC PLK2 UBAP2 DEAF1 FAM90A1 CIT SHANK3 TDRD7 NCOR2 SEC16A OTUD4 YY1AP1 MTUS2 | 1.22e-04 | 679 | 114 | 13 | int:FXR1 |
| Interaction | RBM4B interactions | 1.23e-04 | 262 | 114 | 8 | int:RBM4B | |
| Interaction | NCOR2 interactions | 1.30e-04 | 264 | 114 | 8 | int:NCOR2 | |
| Interaction | NUP50 interactions | 1.40e-04 | 341 | 114 | 9 | int:NUP50 | |
| Interaction | RBBP7 interactions | MYC CHAF1A BAG5 BIRC6 CIT SIRT1 TIPARP ZNF750 NCOR2 SALL1 RPL3 | 1.43e-04 | 507 | 114 | 11 | int:RBBP7 |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 7.32e-13 | 154 | 128 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 6.87e-11 | 234 | 128 | 11 | chr8p23 |
| Cytoband | 9q21.32 | 1.99e-05 | 19 | 128 | 3 | 9q21.32 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp-Endothelial_Tip.Dcn.Mgp-Clu_(Clu)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.19e-07 | 96 | 118 | 6 | 9a1da3809073a4321134bf3767e0a40398b69caa | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-07 | 183 | 118 | 7 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.60e-07 | 186 | 118 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.00e-06 | 198 | 118 | 7 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-06 | 150 | 118 | 6 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-06 | 150 | 118 | 6 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.61e-06 | 172 | 118 | 6 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-06 | 179 | 118 | 6 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 188 | 118 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 188 | 118 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 189 | 118 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-05 | 189 | 118 | 6 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 190 | 118 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 190 | 118 | 6 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 190 | 118 | 6 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 192 | 118 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 193 | 118 | 6 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 193 | 118 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 193 | 118 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 193 | 118 | 6 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 193 | 118 | 6 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 194 | 118 | 6 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 195 | 118 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-05 | 199 | 118 | 6 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Mgp|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 124 | 118 | 5 | b0ed84522180f8cea541461faf7882c57abf8cd4 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 124 | 118 | 5 | 231862f849d8ab73c6a44c782d33ef2f07661baf | |
| ToppCell | Mild/Remission-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.83e-05 | 142 | 118 | 5 | fc5fc2d2b4b976358b8ce762c1f440b20db84103 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 6.00e-05 | 156 | 118 | 5 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-CD163+_Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.76e-05 | 160 | 118 | 5 | 4480a7d6bd48d06b4e5196faac868f31ab7ed3ad | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.38e-05 | 163 | 118 | 5 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.82e-05 | 165 | 118 | 5 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-05 | 169 | 118 | 5 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 177 | 118 | 5 | c2b8a3a149d70f77612759dea34df9e43953c566 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 177 | 118 | 5 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 177 | 118 | 5 | 384f841aa7b2d05815af7885e481f5affc55d897 | |
| ToppCell | facs-Thymus-Epithelium-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 177 | 118 | 5 | 0e9e44119653abfd270e602e5e477a15e774638f | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 178 | 118 | 5 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 181 | 118 | 5 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.21e-04 | 181 | 118 | 5 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-04 | 185 | 118 | 5 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 1.34e-04 | 185 | 118 | 5 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 1.34e-04 | 185 | 118 | 5 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.37e-04 | 186 | 118 | 5 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-04 | 187 | 118 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 190 | 118 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.52e-04 | 190 | 118 | 5 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 190 | 118 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 190 | 118 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.52e-04 | 190 | 118 | 5 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-04 | 190 | 118 | 5 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 190 | 118 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-04 | 190 | 118 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-04 | 192 | 118 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.59e-04 | 192 | 118 | 5 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-04 | 192 | 118 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 1.59e-04 | 192 | 118 | 5 | 7a81652406332afd03a9b3b529e9b5e6c0b54c28 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-04 | 192 | 118 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 192 | 118 | 5 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 193 | 118 | 5 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 193 | 118 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 193 | 118 | 5 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 193 | 118 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 193 | 118 | 5 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 1.63e-04 | 193 | 118 | 5 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 193 | 118 | 5 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 193 | 118 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.63e-04 | 193 | 118 | 5 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.63e-04 | 193 | 118 | 5 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.67e-04 | 194 | 118 | 5 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-04 | 194 | 118 | 5 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 195 | 118 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 195 | 118 | 5 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 195 | 118 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.71e-04 | 195 | 118 | 5 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.79e-04 | 197 | 118 | 5 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 198 | 118 | 5 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 198 | 118 | 5 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-04 | 198 | 118 | 5 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-04 | 198 | 118 | 5 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-04 | 199 | 118 | 5 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-04 | 199 | 118 | 5 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-04 | 199 | 118 | 5 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | Transverse-(2)_B_cell-(24)_B_cell_cycling|Transverse / shred on region, Cell_type, and subtype | 1.92e-04 | 200 | 118 | 5 | e3f9736227151f23f0e331eec0a7a15ce464b517 | |
| ToppCell | Transverse-B_cell-B_cell_cycling|Transverse / Region, Cell class and subclass | 1.92e-04 | 200 | 118 | 5 | 0e270f8019d9f22068ca426d661937262a5cd331 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.92e-04 | 200 | 118 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.92e-04 | 200 | 118 | 5 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.92e-04 | 200 | 118 | 5 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 1.92e-04 | 200 | 118 | 5 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-04 | 200 | 118 | 5 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.92e-04 | 200 | 118 | 5 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| Disease | salivary gland cancer (implicated_via_orthology) | 1.25e-05 | 2 | 105 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 2.02e-05 | 45 | 105 | 4 | C0278701 | |
| Disease | white matter hyperintensity measurement | 1.06e-04 | 302 | 105 | 7 | EFO_0005665 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 1.25e-04 | 5 | 105 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Todd Paralysis | 4.44e-04 | 9 | 105 | 2 | C0234544 | |
| Disease | Paralysed | 4.44e-04 | 9 | 105 | 2 | C0522224 | |
| Disease | alopecia areata (is_marker_for) | 5.54e-04 | 10 | 105 | 2 | DOID:986 (is_marker_for) | |
| Disease | testosterone measurement | AOC1 CCDC73 INSR SRCAP CSMD3 BIRC6 HNRNPC PRMT6 NCOR2 GYS1 LRP5 YY1AP1 LRRC36 | 6.00e-04 | 1275 | 105 | 13 | EFO_0004908 |
| Disease | Influenza | 8.52e-04 | 52 | 105 | 3 | C0021400 | |
| Disease | early cardiac repolarization measurement | 1.11e-03 | 14 | 105 | 2 | EFO_0004885 | |
| Disease | quinate measurement | 1.28e-03 | 15 | 105 | 2 | EFO_0021167 | |
| Disease | urate measurement, bone density | 1.68e-03 | 619 | 105 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | chemokine (C-C motif) ligand 27 measurement | 2.02e-03 | 70 | 105 | 3 | EFO_0008082 | |
| Disease | osteoporosis (implicated_via_orthology) | 2.06e-03 | 19 | 105 | 2 | DOID:11476 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 2.29e-03 | 20 | 105 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | polymyositis | 2.29e-03 | 20 | 105 | 2 | EFO_0003063 | |
| Disease | respiratory symptom measurement, COVID-19 | 2.36e-03 | 74 | 105 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | prostate cancer (is_marker_for) | 2.38e-03 | 156 | 105 | 4 | DOID:10283 (is_marker_for) | |
| Disease | goiter | 3.02e-03 | 23 | 105 | 2 | EFO_0004283 | |
| Disease | short-term memory | 3.27e-03 | 83 | 105 | 3 | EFO_0004335 | |
| Disease | stomach carcinoma (is_marker_for) | 3.29e-03 | 24 | 105 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Leukemia, Myelocytic, Acute | 3.44e-03 | 173 | 105 | 4 | C0023467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFPKSTHVPIPKSAD | 306 | Q6UXB8 | |
| PPTSKSTVEELHEPI | 86 | Q9GZX9 | |
| STPLTPATEPLHDFV | 516 | P54793 | |
| LHISSPLTPAPETVF | 131 | C9JUS6 | |
| PSLPVPLETVDKHGS | 191 | Q8NAG6 | |
| KHPSLKPTTGVEDPA | 331 | Q5CZ79 | |
| KESPEIEPLPFTLAH | 2311 | Q9NR09 | |
| PSLPLSEDAHPSVAK | 171 | Q9UL15 | |
| TGFHLPPPVTSTKSV | 136 | Q7Z407 | |
| HSPSGILEKIPPDSE | 211 | P02730 | |
| TLLPHDPTADVFVTP | 296 | Q8TDN6 | |
| KNTSEEGFPSPTIHP | 136 | B6SEH9 | |
| TEEPPLFSSHKPRGD | 276 | P19801 | |
| LHTPTPSEDAAIPSK | 781 | Q13111 | |
| SPKIPSGFPIEDHET | 266 | Q16581 | |
| PEEHYSSSPEKILSP | 911 | Q9Y485 | |
| EHITKRVASSPAPPE | 1931 | O14578 | |
| LTFTAKPHPSPTSLS | 211 | Q7L9B9 | |
| KPHPSPTSLSLQSED | 216 | Q7L9B9 | |
| SSLLAAPSFHSPEKP | 406 | A6NDY2 | |
| GIPKPVFTHSKDTPS | 596 | Q5JR59 | |
| PHSPFAIKQETPEVS | 301 | Q06710 | |
| PSPAEQKPAEHVSLS | 556 | Q01804 | |
| KLPTDPSSDEPVFHI | 1501 | Q9NZM3 | |
| TDLLHPVSSDVPTSP | 161 | Q7Z3E1 | |
| SSLLAAPSFHSPEKP | 406 | A6NKC0 | |
| LDKASDPHLGTPSPE | 286 | Q12851 | |
| VSPEQPPLFTHTVKD | 511 | Q5JPF3 | |
| SSLLAAPSFHSPEKP | 406 | A8MXZ1 | |
| KTLVSSLHPEPPETG | 336 | Q5HY64 | |
| PPFTITHPVETSSAL | 2451 | Q8WXI7 | |
| SKISTPDHDKSTVPP | 5231 | Q8WXI7 | |
| EPVSPVSSPSLTHDK | 2051 | Q9Y618 | |
| LVGPPLHTPETEESK | 316 | Q9BQK8 | |
| SQPPEDHSPISRKEF | 191 | Q7L273 | |
| PVGETSFSVPLHPTK | 881 | Q6ZMT4 | |
| HKELFTKQPPSTPTS | 1826 | Q8NEZ4 | |
| HPSPSPLLSSSFDLD | 111 | P07910 | |
| HLKEPSGPSELIPSS | 71 | Q96GA3 | |
| TPPITVTHKPEEDTF | 416 | Q16288 | |
| EHIKESTEIPSPFSP | 876 | Q96NW7 | |
| SSLLTAPSFHSPEKP | 406 | Q86YD7 | |
| RKPITPEHSTFITSP | 296 | Q53G44 | |
| PSSTSVFHLDPPVKK | 2031 | Q5HYC2 | |
| EITKPPSDDSPAHSS | 1371 | O75197 | |
| TSHPKPTAADNPELS | 526 | Q13585 | |
| DVFQTTDVPLPKPSH | 6156 | Q5CZC0 | |
| KNTSEEGFPSPTIHP | 136 | B6SEH8 | |
| SSLLAAPSFHSPEKP | 406 | A8MWA6 | |
| SSLLAAPSFHSPEKP | 406 | P0C7W9 | |
| LLEDHPIAPVSSTSP | 176 | A6NKB5 | |
| SPTEKFSLHPLTGEL | 861 | Q9NYQ8 | |
| SSPEKELIPKPDTFH | 286 | Q1X8D7 | |
| LSEPGTDLVEPSPKH | 956 | Q8NEN9 | |
| HEKPFLSSSAPPITS | 861 | Q32MH5 | |
| KPSTSETPLEPHTSE | 41 | A6H8Z2 | |
| PSDTSKPTHPEALTE | 316 | Q8IVU3 | |
| ITPTPFVPFTVSHLK | 141 | Q96G03 | |
| YTIDHTKPTPASTPE | 341 | Q9H3R0 | |
| SSNPHLLSFPSEPLE | 401 | Q6PI73 | |
| TSVPTSPEEHRPFEK | 786 | P06213 | |
| SSLLAAPSFHSPEKP | 406 | P0DV74 | |
| ALHLPASSFLTPPKD | 141 | Q9BZE0 | |
| SSLLAAPSFHSPEKP | 406 | P0DV73 | |
| LSEEPPSKPSFHECI | 726 | Q86Y91 | |
| SSLLAAPSFHSPEKP | 406 | P0DV76 | |
| SSLLAAPSFHSPEKP | 406 | A6NJQ4 | |
| GPSSPSPVKFLIDTH | 1211 | Q6YHK3 | |
| HFESSPLPTSPKFLR | 796 | Q14721 | |
| LSDVHSPPKSPEGKT | 151 | O95684 | |
| PKSPEKHDLNSTETP | 211 | I3L273 | |
| FPEAALPTSHPKIVL | 406 | O75398 | |
| PAELFLIASPSHPTE | 16 | Q96LA6 | |
| TLHTKPEPLEGPALS | 301 | Q9BVV2 | |
| TPESPIFHSPILLEE | 1411 | O75417 | |
| FPTEHVKTKPLISTP | 1006 | Q6ZRK6 | |
| PLSATVFPKVEHSPG | 1256 | Q3T8J9 | |
| IHSFSKERSPSSPVP | 786 | A2RUB6 | |
| SEKPLVLSTSPFHPA | 301 | Q96LA8 | |
| SPETLPKHVLSGSPE | 301 | Q96PX6 | |
| PGPETHLPTSFTLKS | 146 | Q99062 | |
| FETPLSHLRQEPPKT | 306 | Q5JRC9 | |
| KTGVSHLSPEPPKTE | 381 | Q5JRC9 | |
| PPLPSDTFALAHTAT | 616 | Q5VTJ3 | |
| SSLLAAPSFHSPEKP | 406 | A6NIJ5 | |
| PSDPPEHFPLRKTVS | 141 | Q8WUI4 | |
| IFHPEFLSSTSPLLP | 476 | P13807 | |
| ATTPPLPSHLTAEET | 986 | Q13255 | |
| KTPLLDDPVFIHPSS | 956 | Q8IY37 | |
| SSLLAAPSFHSPEKP | 406 | A8MXJ8 | |
| PDEAPTILSVTPHTT | 1501 | Q58EX2 | |
| KTEEPAPIPISHSAT | 571 | Q9NSC2 | |
| SSLLAAPSFHSPEKP | 406 | P0C7X0 | |
| TPTTFKPDSPDLARH | 956 | Q9BZA8 | |
| FEAKPPLSTAHPLTP | 1131 | A6NGG8 | |
| PHSIASPPEDRTVKD | 1821 | Q8NEY1 | |
| KHDPTFEPLFPSETT | 656 | Q9UGT4 | |
| HSETPLCPAVSPKET | 66 | Q96DL1 | |
| SFPKDDPSKPVHLTA | 31 | P39023 | |
| SLEPLEHPLISSPSF | 456 | Q5UIP0 | |
| EPLVLHEETPPTTSS | 236 | P01106 | |
| SSLLAAPSFHSPEKP | 406 | A8MX19 | |
| SSLLAAPSFHSPEKP | 406 | A6NNJ1 | |
| SSLLAAPSFHSPEKP | 406 | P0C7W8 | |
| SSLLAAPSFHSPEKP | 406 | D6RGX4 | |
| HGTTFELVPTSPPKD | 946 | Q92859 | |
| ELPPTPLHVSEDSSS | 526 | Q96EB6 | |
| HSTSEKPSKLPFDTP | 901 | Q93073 | |
| QPVSPLDSKFPIDHS | 221 | Q6ZUB0 | |
| FSTEELPPPVHLSKP | 896 | Q8NHU6 | |
| KLVHSPSPEVSASAP | 1376 | Q6ZRS2 | |
| SSLLAAPSFHSPEKP | 406 | P0C7V4 | |
| PTTIHKSPDESTPEL | 866 | Q92954 | |
| SPPTLEGQHSKPFKE | 231 | O00506 | |
| SPFLPPEFPHKISST | 211 | Q32MQ0 | |
| STTHPVPLTVGKPED | 81 | Q8WWB5 | |
| TDLDHILPSSVLPPF | 6 | Q5T4D3 | |
| QPVSPLDSKFPIDHS | 221 | P0C874 | |
| SHLDFKSQPEPSPVL | 421 | Q5T6F2 | |
| SSRPTSPEKFSVPHV | 1436 | O15027 | |
| TLPSTHVTPSEPKPF | 2861 | Q15772 | |
| HVTPSEPKPFVLDTG | 2866 | Q15772 | |
| STFIHPLTGKPLDPS | 1091 | Q9BYB0 | |
| VPPSTEHLDPLLKDA | 211 | Q6P1M0 | |
| VSPLDSKFPIDHSPP | 226 | Q6ZQQ2 | |
| LVEPHSPSPSSKFST | 571 | O15014 | |
| EPSLTSDELHLPGKP | 381 | Q8IZN3 | |
| PPKTEDHDTPAPFTS | 206 | O15060 | |
| SPLSATVFPKVEHSP | 711 | Q9H869 | |
| PKTTEPTFSHLALPE | 86 | Q08ER8 | |
| PSKHRTDEELQPPTT | 411 | Q9NYY3 | |
| PPALEASLVTEPTKH | 696 | Q5JPB2 | |
| HAPSDTIPESPKLEQ | 306 | Q9BR11 | |
| VDFSITKRPHTPTPG | 191 | P62995 | |
| FASETPLEKEPHSPA | 1316 | Q9H2Y7 | |
| IPHLSSPPTKFFVST | 1391 | Q96QT4 | |
| SSPIKQSHEPVPDTS | 366 | Q9ULM3 | |
| VTKFLSSSPHLPPSS | 426 | O14773 | |
| SSLLAAPSFHSPEKP | 406 | P0DV75 | |
| EDPAPSRKIHFSTAP | 441 | Q96SB3 |